Scinovex
article Open Access

Study to estimate platelet lymphocyte ratio in acute coronary syndrome as a prognostic marker

International Journal of Advanced Research in Medicine · 2021 · Vol. 3(2) · pp. 445–451

Abstract

Background: Acute Coronary Syndrome is a big burden in India due to urbanization and economic transition. Risk stratification in the emergency room is important for initiating appropriate therapy. Acute Coronary Syndrome has an inflammatory process due to atherosclerosis in which platelets are elevated and lymphocytes are reduced. Earlier studies have tried using Platelet Lymphocyte Ratio in determining the severity of the Acute Coronary event. Objective: This study aims is to use Platelet Lymphocyte Ratio in Acute Coronary Syndrome as a marker of prognosis. Methods: We conducted a single centre cross-sectional study of 100 random patients with Acute Coronary Syndrome during the study period from November 2019 to October 2021. Results: There was a statistically significant (p=0.0001) correlation between Platelet Lymphocyte Ratio and GRACE score, TIMI score in Acute Coronary Syndrome. Conclusion: Platelet Lymphocyte Ratio can be used as a prognostic marker in Acute Coronary Syndrome.

Inflammatory Biomarkers in Disease PrognosisAcute Myocardial Infarction ResearchHeart rate and cardiovascular healthMedicineAcute coronary syndromeInternal medicinePlateletLymphocyteTIMICardiologyPredictive markerMyocardial infarctionThrombolysis
Citations
0
FWCI
0.00
field-weighted impact
References
16
Percentile
24%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Study to estimate platelet lymphocyte ratio in acute coronary syndrome as a prognostic marker · Scinovex